Role: Working with many different disease models and preclinical imaging. Assistance in planning and practical execution of in vivo experiments and preclinical PET imaging studies.
Role: Scheduling and technical operation of PET scanners used in the groups preclinical trials and updating the imaging/trial database.
Project: Molecular imaging of caldiovascular disease in type-2 diabetes: evaluation of experimental models and their responses to treatment.
Funding: Drug Research Doctoral Programme, Turku University Foundation.
Project: Molecular imaging of cardiac inflammation using new PET tracers in experimental models.
Funding: Doctoral Program of Clinical Research, Finnish Foundation for Cardiovascular Research
Project: Determining the effects of diet, microbiological status and microbiota on the metabolic phenotype of ApoE-/- mice as a model for drug development .
Project: Radiosynthesis of [18F](2S, 4R)4-Fluoroglutamine for in-vivo PET imaging.
Funding: Drug research Doctoral Program, Finnish Cultural Foundation.
Project: Development of Positron Emission Tomography (PET) Imaging Agent Targeting Macrophage Mannose Receptor (MMR) in Cardiovascular Disease and Cancer.
Funding: Turku University Foundation.
Project: Molecular imaging in myocardial infarction.
Radiopharmaceutical 18F-PEG-Folate: Radiosynthesis and evaluation of in vitro binding and in vivo imaging of inflammation.
Project: Folate receptor beta as an imaging target in myocardial infarction.